Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: Programmatic implications for countries phasing out stavudine
Journal of Infectious Diseases, Volume 207, No. SUPPL.2, Year 2013